Lupin Pharmaceuticals has voluntarily recalled 43,860 bottles of moxifloxacin ophthalmic solution due to failed impurities or degradation specifications, according to an FDA Enforcement Report.Used to treat bacterial conjunctivitis, the antibiotic was …
Author: Healio ophthalmology
Autologous platelet-rich plasma may treat extreme ocular hypotension
ATHENS, Greece — Autologous platelet-rich plasma showed efficacy in treating extreme ocular hypotension in a series of patients presented here at the European Society of Cataract and Refractive Surgeons Winter Meeting.“PRP is a blood-derived product th…
Intracorneal inlay shows good results, spectacle independence
ATHENS, Greece — Implantation of the Presbia Flexivue Microlens showed good results at 6 months in a group of patients and may be a good option for spectacle-free everyday life, according to one surgeon.“Although many people say that the cornea should …
FDA accepts Clearside’s NDA for Xipere suprachoroidal injection
The FDA has accepted a new drug application for Xipere suprachoroidal injection for the treatment of macular edema associated with uveitis, according to a Clearside Biomedical press release.“Macular edema is the leading cause of vision loss, and even b…
One-year results of individualized cross-linking in ultra-thin corneas show promise
ATHENS, Greece — Individualized corneal cross-linking, in which UV fluence is adapted to individual stromal thickness, may be an option for stabilizing keratoconus in patients with thin corneas, according to 1-year study results.“Two years ago, our gro…
VIDEO: Surgeon presents long-term results of topography-guided refractive surgery techniques
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons Winter Meeting, A. John Kanellopoulos, MD, talks about the superior outcomes of using topography-modified refraction as compared with clinical refraction in treating cylinder …
VIDEO: Surgeon presents long-term results of topography-guided refractive surgery techniques
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons Winter Meeting, A. John Kanellopoulos, MD, talks about the superior outcomes of using topography-modified refraction as compared with clinical refraction in treating cylinder …
Surgeons perform first gene therapy procedure aimed at stopping AMD-related blindness
Researchers have completed the first gene therapy procedure aimed at stopping age-related macular degeneration.The operation was performed at John Radcliffe Hospital, Oxford, England, by Robert MacLaren, FRCOphth, a professor of ophthalmology at the Un…
Eyenovia enrolling broad patient population in MicroProst phase 3 trial
Eyenovia will include a broad patient population, including patients with chronic angle closure glaucoma, open-angle glaucoma and ocular hypertension, in a phase 3 trial of MicroProst, according to a press release.MicroProst (microdose latanoprost with…
Wage-fixing and no-poach agreements
Antitrust laws are intended to ensure that firms compete fairly in an open marketplace, including to hire or retain employees. Physician practices that agree with each other not to compete for employees face significant antitrust risk unless those agre…
Combination of PRK, cross-linking shows good results over 4 years
ATHENS, Greece — A combination of PRK and accelerated corneal cross-linking, called PRK Xtra, may be a way to perform refractive surgery in eyes with suspicious corneal topography, according to a study presented at the European Society of Cataract and …
VIDEO: Corneal inlays, a technology that has struggled to take off
ATHENS, Greece — At the European Society of Cataract and Refractive Surgeons Winter Meeting, Ioannis Pallikaris, MD, PhD, speaks about the troubled history of corneal inlays and gives his perspective on this still controversial method of correcting pre…
Pr3vent closes Series A funding round for AI development
Pr3vent, which is developing artificial intelligence for early detection of preventable vision loss in healthy term newborn infants, closed a round of Series A financing led by InFocus Capital Partners.“This financing round puts Pr3vent in a strong pos…
ESCRS president announces new initiatives at winter meeting
ATHENS, Greece — With close to 2,000 delegates from seven countries and 34 exhibiting companies, the European Society of Cataract and Refractive Surgeons Winter Meeting shows constant growth and appreciation. There were more than 1,000 attendees from G…
Stanford’s WellMD Center blazes a trail to promote joy in medicine, combat burnout
Physician burnout has become a topic of interest in the medical community in recent years, with the level of urgency increasing on what seems like a weekly basis.In a recent paper, experts at Harvard and the Massachusetts Medical Society declared physi…
David F. Chang, MD, discusses video of a complex cataract surgery
ORLANDO ― In his video presentation from Cataract Surgery: Telling It Like It Is, David F. Chang, MD, shows complications that arose in a case of a rock hard cataract in an eye with coloboma. Additional comments and insights on the panel come from Rich…
Three videos show how to handle complications of capsulorrhexis in cataract surgery
ORLANDO ― In his video presentation from Cataract Surgery: Telling It Like It Is, Brian Little, FRCS, FRCOphth, FEHA, consultant and training director of the cataract service at Moorfields Eye Hospital in London, shows three different complications he …
Negative dysphotopsia improves with occlusion of contralateral eye
ORLANDO — Samuel Masket, MD, has spent a lot of time thinking about negative dysphotopsia and how to improve it.In a presentation at Cataract Surgery: Telling It Like It Is, Masket related findings of a 25-eye pilot study in which patients with ND scot…
Provectus ocular melanoma treatment gets orphan drug designation
The FDA has granted an orphan drug designation to PV-10, Provectus BioPharmaceuticals’ ocular melanoma treatment candidate, according to a press release.Rose bengal disodium, also called PV-10, is a small molecule oncolytic immunotherapy delivered via …
Regeneron reports revenue increase for 2018
Regeneron reported its fourth quarter 2018 GAAP net income at $820 million, a 371% increase from the fourth quarter 2017 GAAP net income.For the full year, Regeneron reported $2.4 billion in GAAP net income, a 104% increase over the 2017 full year.Net …